Effect of the surface modification, size, and shape on cellular uptake of nanoparticles

Cell Biology International

Volumn 39, Issue 8, 2015, Pages 881-890

  Salatin, Sara ^a,b   Maleki Dizaj, Solmaz ^a,b   Yari Khosroushahi, Ahmad ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TABRIZ   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Drug delivery; Endocytosis; Nanosize; Negative charge; Neutral charge; Positive charge

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; APOLIPOPROTEIN B; APOLIPOPROTEIN E; BOVINE SERUM ALBUMIN; CHITOSAN; CYCLODEXTRIN; GOLD NANOPARTICLE; IRON OXIDE; LEUCINE ENKEPHALIN[2 DEXTRO ALANINE 6 ARGININE]; LOPERAMIDE; MACROGOL; NANOCARRIER; NANOPARTICLE; NANOROD; POLOXAMER; POLYESTER; POLYETHYLENEIMINE; POLYGLACTIN; POLYSORBATE 80; POLYSTYRENE; POLYVINYL ALCOHOL; SILICA NANOPARTICLE; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN; DRUG CARRIER;

ANTINOCICEPTION; BIOCOMPATIBILITY; CELL DIVISION; CELL TRANSPORT; CHEMICAL MODIFICATION; ENDOCYTOSIS; PARTICLE SIZE; PHAGOCYTOSIS; PHYSICAL CHEMISTRY; PINOCYTOSIS; REVIEW; SURFACE CHARGE; SURFACE PROPERTY; CELL MEMBRANE; CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; METABOLISM; PHYSIOLOGY; STRUCTURE ACTIVITY RELATION;

CELL MEMBRANE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; HUMANS; NANOPARTICLES; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PROPERTIES;

EID: 84937631901     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10459     Document Type: Review

References (100)

1. Agarwal R, Singh V, Jurney P, Shi L, Sreenivasan S, Roy K ( 2013) Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms. Proc Natl Acad Sci 110: 17247-52.
2. Amidi M, Mastrobattista E, Jiskoot W, Hennink WE ( 2010) Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Del Rev 62: 59-82.
3. Arvizo RR, Miranda OR, Thompson MA, Pabelick CM, Bhattacharya R, Robertson JD, Rotello VM, Prakash Y, Mukherjee P ( 2010) Effect of nanoparticle surface charge at the plasma membrane and beyond. Nano Lett 10: 2543-8.
4. Asati A, Santra S, Kaittanis C, Perez JM ( 2010) Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles. ACS Nano 4: 5321-3.
5. Au C, Mutkus L, Dobson A, Riffle J, Lalli J, Aschner M ( 2007) Effects of nanoparticles on the adhesion and cell viability on astrocytes. Biol Trace Elem Res 120: 248-56.
6. Ayala V, Herrera AP, Latorre-Esteves M, Torres-Lugo M, Rinaldi C ( 2013) Effect of surface charge on the colloidal stability and in vitro uptake of carboxymethyl dextran-coated iron oxide nanoparticles. J Nanopart Res 15: 1-14.
7. Bramini M, Ye D, Hallerbach A, Nic Raghnaill M, Salvati A, Åberg C, Dawson KA ( 2014) Imaging approach to mechanistic study of nanoparticle interactions with the blood-brain barrier. ACS Nano 8: 4304-12.
8. Brandenberger C, Mühlfeld C, Ali Z, Lenz AG, Schmid O, Parak WJ, Gehr P, Rothen-Rutishauser B ( 2010) Quantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticles. Small 6: 1669-78.
9. Chithrani BD, Ghazani AA, Chan WC ( 2006) Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6: 662-8.
10. Chiu Y-L, Ho Y-C, Chen Y-M, Peng S-F, Ke C-J, Chen K-J, Mi F-L, Sung H-W ( 2010) The characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically-modified chitosan. J Con Rel 146: 152-9.
11. Cho EC, Au L, Zhang Q, Xia Y ( 2010) The effects of size, Shape, and surface functional group of gold nanostructures on their adsorption and internalization by cells. Shape 6: 517-22.
12. Cho K, Wang X, Nie S, Shin DM ( 2008) Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 14: 1310-6.
13. Choi J, Zhang Q, Reipa V, Wang NS, Stratmeyer ME, Hitchins VM, Goering PL ( 2009) Comparison of cytotoxic and inflammatory responses of photoluminescent silicon nanoparticles with silicon micron-sized particles in RAW 264.7 macrophages. J Appl Toxicol 29: 52-60.
14. Chu Z, Zhang S, Zhang B, Zhang C, Fang C-Y, Rehor I, Cigler P, Chang H-C, Lin G, Liu R ( 2014) Unambiguous observation of shape effects on cellular fate of nanoparticles. Sci Rep 4.
15. Cornejo-Monroya D, Acosta-Torresb LS, Moreno-Vegac AI, Saldanad C, Morales-Tlalpand V, Castañoc VM ( 2013) Gold nanostructures in medicine: past, present and future. J Nanosci Lett 3: 25.
16. Dasgupta S, Auth T, Gompper G ( 2014) Shape and orientation matter for the cellular uptake of nonspherical particles. Nano Lett 14: 687-93.
17. Dionísio M, Cordeiro C, Remuñán-López C, Seijo B, Rosa daCosta, Grenha A ( 2013) Pullulan-based nanoparticles as carriers for transmucosal protein delivery. Eur J Phar Sci 50: 102-13.
18. Donkor DA, Tang XS ( 2014) Tube length and cell type-dependent cellular responses to ultra-short single-walled carbon nanotube. Biomaterials 35: 3121-3.
19. Duceppe N, Tabrizian M ( 2010) Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery. Exp Drug Del 7: 1191-207.
20. Ehrenberg MS, Friedman AE, Finkelstein JN, Oberdörster G, McGrath JL ( 2009) The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials 30: 603-10.
21. El-Shabouri M( 2002) Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int J Phar 249: 101-8.
22. Feczkó T, Tóth J, Gyenis J ( 2008) Comparison of the preparation of PLGA-BSA nano-and microparticles by PVA, poloxamer and PVP. Colloid Surface A 319: 188-95.
23. Gan Q, Wang T, Cochrane C, McCarron P ( 2005) Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloid Surface B 44: 65-73.
24. Ghosh P, Han G, De M, Kim CK, Rotello VM ( 2008) Gold nanoparticles in delivery applications. Adv Drug Del Rev 60: 1307-15.
25. Giljohann DA, Seferos DS, Patel PC, Millstone JE, Rosi NL, Mirkin CA ( 2007) Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles. Nano Lett 7: 3818-21.
26. Gratton SE, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, DeSimone JM ( 2008) The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci 105: 11613-8.
27. Gref R, Domb A, Quellec P, Blunk T, Müller R, Verbavatz J, Langer R ( 1995) The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Del Rev 16: 215-33.
28. Gupta AK, Gupta M ( 2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26: 3995-4021.
29. Gupta AK, Gupta M, Yarwood SJ, Curtis AS ( 2004) Effect of cellular uptake of gelatin nanoparticles on adhesion, morphology and cytoskeleton organisation of human fibroblasts. J Con Rel 95: 197-20.
30. Hanada S, Fujioka K, Inoue Y, Kanaya F, Manome Y, Yamamoto K ( 2014) Cell-based in vitro blood-brain barrier model can rapidly evaluate nanoparticles' brain permeability in association with particle size and surface modification. Int J Mol Sci 15: 1812-25.
31. Harush-Frenkel O, Debotton N, Benita S, Altschuler Y ( 2007) Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochem Biophys Res Commun 353: 26-32.
32. He C, Hu Y, Yin L, Tang C, Yin C ( 2010) Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31: 3657-66.
33. He Q, Zhang Z, Gao Y, Shi J, Li Y ( 2009) Intracellular localization and cytotoxicity of spherical mesoporous silica nano-and microparticles. Small 5: 2722-9.
34. Hou Y, Cai K, Li J, Chen X, Lai M, Hu Y, Luo Z, Ding X, Xu D ( 2013) Effects of titanium nanoparticles on adhesion, migration, proliferation, and differentiation of mesenchymal stem cells. Int J Nanomed 8: 3619.
35. Howard KA( 2009) Delivery of RNA interference therapeutics using polycation-based nanoparticles. Adv Drug Del Rev 61: 710-2.
36. Hu M, Chen J, Li Z-Y, Au L, Hartland GV, Li X, Marquez M, Xia Y ( 2006) Gold nanostructures: engineering their plasmonic properties for biomedical applications. Chem Soc Rev 35: 1084-9.
37. Huang X, Teng X, Chen D, Tang F, He J ( 2010) The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials 31: 438-4.
38. Janát-Amsbury M, Ray A, Peterson C, Ghandehari H ( 2011) Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm 77: 417-23.
39. Jiang W, Kim BY, Rutka JT, Chan WC ( 2008) Nanoparticle-mediated cellular response is size-dependent. Nature Nanotechnol 3: 145-50.
40. Jiang X, Weise S, Hafner M, Röcker C, Zhang F, Parak WJ, Nienhaus GU ( 2009) Quantitative analysis of the protein corona on FePt nanoparticles formed by transferrin binding. J R Soc Interface 7: 5-13.
41. Jung S-W, Jeong Y-I, Kim S-H ( 2003) Characterization of hydrophobized pullulan with various hydrophobicities. Int J Pharm 254: 109-21.
42. Karataş ÖF, Sezgin E, Aydin Ö, Çulha M ( 2009) Interaction of gold nanoparticles with mitochondria. Colloid Surface B 71: 315-8.
43. Kelf T, Sreenivasan V, Sun J, Kim E, Goldys E, Zvyagin A ( 2010) Non-specific cellular uptake of surface-functionalized quantum dots. Nanotechnol 21: 285105.
44. Kim JA, Åberg C, Salvati A, Dawson KA ( 2012) Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. Nat Nanotechnol 7: 62-8.
45. Kolhar P, Anselmo AC, Gupta V, Pant K, Prabhakarpandian B, Ruoslahti E, Mitragotri S ( 2013) Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium. Proc Natl Acad Sci 110: 10753-8.
46. Kolosnjaj-Tabi J, Wilhelm C, Clément O, Gazeau F ( 2013) Cell labeling with magnetic nanoparticles: opportunity for magnetic cell imaging and cell manipulation. J Nanobiotechnol 11: S7.
47. Kreuter J ( 2013) Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB). J Microencaps 30: 49-54.
48. Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, Alyautdin R ( 2002) Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Targeting 10: 317-25.
49. Lankoff A, Arabski M, Wegierek-Ciuk A, Kruszewski M, Lisowska H, Banasik-Nowak A, Rozga-Wijas K, Wojewodzka M, Slomkowski S ( 2011) Effect of surface modification of silica nanoparticles on toxicity and cellular uptake by human peripheral blood lymphocytes in vitro. Nanotoxicol 7: 235-50.
50. Lemarchand C, Gref R, Couvreur P ( 2004) Polysaccharide-decorated nanoparticles. Eur J Pharm Biopharm 58: 327-41.
51. Liu Y, Tsapis N, Edwards DA ( 2003) Investigating sustained-release nanoparticles for pulmonary drug delivery. Cambridge, Massachusetts: Harvard University.
52. Lohcharoenkal W, Wang L, Chen YC, Rojanasakul Y ( 2014) Protein nanoparticles as drug delivery carriers for cancer therapy. BioMed Res Int 2014: 1-12.
53. Lu C-W, Hung Y, Hsiao J-K, Yao M, Chung T-H, Lin Y-S, Wu S-H, Hsu S-C, Liu H-M, Mou C-Y ( 2007) Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. Nano Lett 7: 149-54.
54. Lu F, Wu SH, Hung Y, Mou CY ( 2009) Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 5: 1408-13.
55. Luissint A-C, Artus C, Glacial F, Ganeshamoorthy K, Couraud P-O ( 2012) Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation. Fluids Barriers CNS 9: 23.
56. Lynch I, Dawson KA ( 2008) Protein-nanoparticle interactions. Nano Today 3: 40-7.
57. Merisko-Liversidge EM, Liversidge GG ( 2008) Drug nanoparticles: formulating poorly water-soluble compounds. Toxicol Pathol 36: 43-8.
58. Morishita M, Peppas NA ( 2006) Is the oral route possible for peptide and protein drug delivery? Drug Discov Today 11: 905-10.
59. Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM ( 2008) Nano/micro technologies for delivering macromolecular therapeutics using poly (d, l-lactide- co-glycolide) and its derivatives. J Con Rel 125: 193-209.
60. Oh N, Park J-H ( 2014) Endocytosis and exocytosis of nanoparticles in mammalian cells. Int J Nanomed 9: 51.
61. Oyewumi MO, Yokel RA, Jay M, Coakley T, Mumper RJ ( 2004) Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. J Con Rel 95: 613-26.
62. Panyam J, Dali MM, Sahoo SK, Ma W, Chakravarthi SS, Amidon GL, Levy RJ, Labhasetwar V ( 2003) Polymer degradation and in vitro release of a model protein from poly (d, l-lactide- co-glycolide) nano-and microparticles. J Con Rel 92: 173-87.
63. Panyam J, Labhasetwar V ( 2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Del Rev 55: 329-47.
64. Pearson RM, Juettner VV, Hong S ( 2014) Biomolecular corona on nanoparticles: a survey of recent literature and its implications in targeted drug delivery. Front chem 2: 1-7.
65. Pelkmans L, Helenius A ( 2002) Endocytosis via caveolae. Traffic 3: 311-20.
66. Pietroiusti A, Campagnolo L, Fadeel B ( 2013) Interactions of engineered nanoparticles with organs protected by internal biological barriers. Small 9: 1557-72.
67. Pratten MK, Lloyd JB ( 1986) Pinocytosis and phagocytosis: the effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro. Biochimica et Biophysica Acta 881: 307-13.
68. Prijic S, Scancar J, Cemazar M, Bregar VB, Znidarsic A, Sersa G ( 2010) Increased cellular uptake of biocompatible superparamagnetic iron oxide nanoparticles into malignant cells by an external magnetic field. J Membrane Biol 236: 167-79.
69. Raffa V, Ciofani G, Vittorio O, Riggio C, Cuschieri A ( 2010) Physicochemical properties affecting cellular uptake of carbon nanotubes. Nanomedicine 5: 89-97.
70. Rejman J, Oberle V, Zuhorn I, Hoekstra D ( 2004) Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem J 377: 159-6.
71. Rosi NL, Giljohann DA, Thaxton CS, Lytton-Jean AK, Han MS, Mirkin CA ( 2006) Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312: 1027-30.
72. Sahoo SK, Panyam J, Prabha S, Labhasetwar V ( 2002) Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Con Rel 82: 105-14.
73. Salvati A, Pitek AS, Monopoli MP, Prapainop K, Bombelli FB, Hristov DR, Kelly PM, Åberg C, Mahon E, Dawson KA ( 2013) Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol 8: 137-43.
74. Saptarshi SR, Duschl A, Lopata AL ( 2013a) Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotechnol 11: 1-12.
75. Saptarshi SR, Duschl A, Lopata AL ( 2013b) Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotechnol 11: 1-12.
76. Serdiuk T, Lysenko V, Mognetti B, Skryshevsky V, Géloën A ( 2013) Impact of cell division on intracellular uptake and nuclear targeting with fluorescent SiC-based nanoparticles. J Biophotonics 6: 291-7.
77. Shang L, Nienhaus K, Nienhaus GU ( 2014) Engineered nanoparticles interacting with cells: size matters. J Nanobiotechnol 12: 5.
78. Shen J, Kim H-C, Su H, Wang F, Wolfram J, Kirui D, Mai J, Mu C, Ji L-N, Mao Z-W ( 2014) Cyclodextrin and Polyethylenimine Functionalized Mesoporous Silica Nanoparticles for Delivery of siRNA Cancer Therapeutics. Theranostics 4: 487.
79. Storm G, Belliot SO, Daemen T, Lasic DD ( 1995) Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Del Rev 17: 31-48.
80. Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y ( 2009) Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells. Int J Pharm 382: 198-204.
81. Takahashi H, Niidome T, Kawano T, Yamada S, Niidome Y ( 2008) Surface modification of gold nanorods using layer-by-layer technique for cellular uptake. J Nanopart Res 10: 221-8.
82. Teodoro JS, Simões AM, Duarte FV, Rolo AP, Murdoch RC, Hussain SM, Palmeira CM ( 2011) Assessment of the toxicity of silver nanoparticles in vitro: A mitochondrial perspective. Toxicol In Vitro 25: 664-70.
83. Treuel L, Jiang X, Nienhaus GU ( 2013) New views on cellular uptake and trafficking of manufactured nanoparticles. J R Soc Interface 10: 1-14.
84. Truong NP, Whittaker MR, Mak CW, Davis TP ( 2014) The importance of nanoparticle shape in cancer drug delivery. Expert Opinion Drug Del 2: 1-14.
85. Vasir JK, Labhasetwar V ( 2008) Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles. Biomaterials 29: 4244-52.
86. Vercauteren D, Vandenbroucke RE, Jones AT, Rejman J, Demeester J, De Smedt SC, Sanders NN, Braeckmans K ( 2009) The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls. Mol Ther 18: 561-9.
87. Verma A, Stellacci F ( 2010) Effect of surface properties on nanoparticle-cell interactions. Small 6: 12-21.
88. Voigt J, Christensen J, Shastri VP ( 2014) Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae. Proc Natl Acad Sci 111: 2942-7.
89. Wagner S, Zensi A, Wien SL, Tschickardt SE, Maier W, Vogel T, Worek F, Pietrzik CU, Kreuter J, Von Briesen H ( 2012) Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model. PLoS ONE 7: e32568.
90. Wahab BA, Evgenivetch PV, Alyautdin RN ( 2005) Brain targeting of nerve growth factor using poly (butylcyanoacrylate) nanoparticles. Int J Pharmacol 3: 2.
91. Walkey CD, Olsen JB, Guo H, Emili A, Chan WC ( 2012) Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc 134: 2139-47.
92. Wang L, Zhang H, Chen B, Xia G, Wang S, Cheng J, Shao Z, Gao C, Bao W, Tian L ( 2012) Effect of magnetic nanoparticles on apoptosis and cell cycle induced by wogonin in Raji cells. Int J Nanomed 7: 789-98.
93. Wilhelm C, Billotey C, Roger J, Pons J, Bacri J-C, Gazeau F ( 2003) Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 24: 1001-1.
94. Yang L, Watts DJ ( 2005) Particle surface characteristics may play an important role in phytotoxicity of alumina nanoparticles. Toxicol Lett 158: 122-3.
95. Yang ST, Liu Y, Wang YW, Cao A ( 2013) Biosafety and bioapplication of nanomaterials by designing protein-nanoparticle interactions. Small 9: 1635-53.
96. Yin Win, Feng S-S ( 2005) Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26: 2713-22.
97. Yu J, Baek M, Chung H, Choi S ( 2011) Effects of physicochemical properties of zinc oxide nanoparticles on cellular uptake. Paper presented at: J Phys Conf Ser (IOP Publishing).
98. Yu J, Zhao H, Ye L, Yang H, Ku S, Yang N, Xiao N ( 2009) Effect of surface functionality of magnetic silica nanoparticles on the cellular uptake by glioma cells in vitro. J Mater Chem 19: 1265-70.
99. Zhang L, Gu F, Chan J, Wang A, Langer R, Farokhzad O ( 2007) Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 83: 761-9.
100. Zhang Y, Kohler N, Zhang M ( 2002) Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 23: 1553-61.